Including the additional evidence that soluble LBP and CRP were also elevated in patients’ sera, these factors along with sCD14 constituted a collective immune profile that was distinct for ALS and further increased the specificity and sensitivity for the disease. This evidence concerns the gene CRP and amyotrophic lateral sclerosis.